Optimizing blood collection, transport and storage conditions for cell free DNA increases access to prenatal testing

Maternal plasma DNA stabilized for 0 to 7 days in Streck BCTs can be used for non-invasive prenatal molecular applications, when temperatures are maintained within the broad parameters assessed in this study.